Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1986 Aug;22(2):155-9.
doi: 10.1111/j.1365-2125.1986.tb05243.x.

Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin

Clinical Trial

Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin

W Kirch et al. Br J Clin Pharmacol. 1986 Aug.

Abstract

In a placebo controlled double-blind study including 10 patients with heart failure the nisoldipine/digoxin interaction was studied. Nisoldipine was shown to elevate digoxin plasma concentrations significantly by about 15% (trough levels). During chronic combination therapy with nisoldipine trough levels and plasma concentrations 4 h after the morning dose of digoxin were 1.35 +/- 0.14 and 1.92 +/- 0.16 ng ml-1 respectively, whereas they averaged to 1.16 +/- 0.14 and 1.52 +/- 0.16 ng ml-1 with digoxin and placebo (P less than 0.05; mean +/- s.e. mean). Systolic time intervals were significantly altered by nisoldipine co-administration compared with digoxin plus placebo. In certain patients the elevation of digoxin plasma levels due to nisoldipine co-administration could be of clinical relevance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Circulation. 1968 Feb;37(2):149-59 - PubMed
    1. Am Heart J. 1986 Feb;111(2):325-9 - PubMed
    1. Arzneimittelforschung. 1980;30(12):2144-62 - PubMed
    1. Eur J Clin Pharmacol. 1982;22(2):117-22 - PubMed
    1. Clin Pharmacol Ther. 1982 Nov;32(5):562-5 - PubMed

Publication types